BRANDY HOLDER: Open Payments
NPI 1174153357 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 21 payments from 13 companies in 2025. Trend: 2023 $159 · 2024 $471 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $47 |
| Dexcom, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Novo Nordisk Inc | 2 | $39 |
| PFIZER INC. | 2 | $34 |
| SANOFI PASTEUR INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Boston Scientific Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: VRAYLAR, Dexcom G6 Transmitter, CAPLYTA, ELIQUIS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, General - Erectile Dysfunction, Ozempic, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
